TUDCA treatment for breastfeeding mothers with liver concerns
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests whether a medication called TUDCA can help breastfeeding mothers who have a liver condition called MASLD (a type of fatty liver disease linked to metabolism) and whose breast milk shows certain warning signs. The goal is to see if it's safe and effective for both mother and baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are within 72 hours after giving birth
- You plan to breastfeed or give expressed breast milk during the study
- You have MASLD (metabolic dysfunction-associated steatotic liver disease, a form of fatty liver)
- Your breast milk sample shows a high-risk bile acid pattern (detected by a specific test)
- Your newborn is healthy enough to eat by mouth and was born at least 37 weeks of pregnancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
This trial tests a supplement called TOTUM-448 to see if it can reduce liver fat and improve heart health in people with a fatty liver condition (MASLD). If you have excess liver fat and are overweight, this study could help find new ways to manage your condition.
This trial tests adding tauroursodeoxycholic acid (a bile acid supplement) to standard immunotherapy (PD-1/PD-L1 drugs) for people with advanced liver cancer that cannot be removed by surgery. It aims to see if the combination works better than immunotherapy alone.
This trial tests if tirzepatide, a diabetes and weight loss medication, can help improve fatty liver disease in people who are overweight or have obesity. It may offer a new treatment option for managing liver health.
This study tests whether a live-streamed exercise program can improve liver health in pregnant women who have MASLD (a type of fatty liver disease). If you join, you'll be asked to follow exercise sessions at home while researchers track your liver health.
This study looks at how the timing of meals throughout the day affects your metabolism and health. It involves tracking your eating patterns and answering health questions using your phone or computer.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.